DNA — GINKGO BIOWORKS HOLDINGS INC

Ownership history in Caption Management, LLC  ·  7 quarters on record

This page tracks every 13F SEC filing in which Caption Management, LLC reported a position in GINKGO BIOWORKS HOLDINGS INC (DNA). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.02% (2024 Q3)
Avg. % of fund
0.01%
First filed
2021 Q4
Last filed
2025 Q3
Quarters held
7
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 60,000 +45,000 +300.0% 0.01% $875K $14.58
2025 Q3 REDUCED 15,000 -4,998 -25.0% 0.00% $219K $14.58
2024 Q4 REDUCED 19,998 -95,674 -82.7% 0.00% $196K $9.82
2024 Q3 ADDED 115,672 +90,672 +362.7% 0.02% $943K $8.15
3 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    DNA price (monthly, adj. close)

Other funds also holding DNA

As of 2025 Q4 — sorted by position size

Anchorage Capital Group, L.L.C. 3Y 7Y 16.39% Madrona Venture Group, LLC 3Y 1.6% FORBES J M & CO LLP 3Y 7Y 0.7% PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. 3Y 7Y 0.42% Coastal Bridge Advisors, LLC 3Y 7Y 0.17% NANO CAP NEW MILLENNIUM GROWTH FUND L P 0.14% Erste Asset Management GmbH 0.14% Green Alpha Advisors, LLC 3Y 0.11% VIKING GLOBAL INVESTORS LP 3Y 7Y 0.08% ALLEN OPERATIONS LLC 3Y 7Y 0.06%
← Back to Caption Management, LLC Holdings